Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
View All Featured ArticlesHeadline News
Gilead expands access plans for investigational Ebola antiviral obeldesivir
FDA grants accelerated approval to Nelkarmi for previously treated ALK-positive lung cancer
KarXT shows preliminary symptom improvements in Phase III Alzheimer’s psychosis studies
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Operational Excellence in Process Development in Drug Substance Production
Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics, Klaus Mauch, CEO at Insilico Biotechnology AG
11th February 2021
Establishing Early Development Strategies For Therapeutics Proteins
Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs
21st October 2020
Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L
Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Column Packing Protocol for Amsphere A3
Strategy Emerging Markets for Risk Mitigation
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















